Quick Answer
AVAI BIO, INC. reported Shares Outstanding of 137.36 million shares for fiscal year 2025.
AVAI BIO, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 137.36M | +17.2% |
| 2024 | 117.17M | +204.3% |
| 2023 | 38.50M | +46.3% |
| 2022 | 26.32M | +0.1% |
| 2021 | 26.28M | +2369.9% |
| 2020 | 1.06M | -78.8% |
| 2019 | 5.01M | +25.4% |
| 2018 | 4.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 138.03M | +0.7% | +0.1% |
| September 30, 2025 | 137.83M | +4.5% | +0.2% |
| June 30, 2025 | 137.51M | +17.5% | +0.1% |
| March 31, 2025 | 137.36M | +17.2% | +0.2% |
| December 31, 2024 | 137.13M | +61.7% | +4.0% |
| September 30, 2024 | 131.87M | +104.4% | +12.7% |
| June 30, 2024 | 117.02M | +81.4% | -0.1% |
| March 31, 2024 | 117.17M | +204.3% | +38.2% |
- AVAI BIO, INC. showed an increase of +17.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, AVAI BIO, INC.’s shares outstanding has grown by 3334.1% (from 4.00 million shares to 137.36 million shares).
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: